Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
    • Subscribe
Advertisement

News

Article

April 17, 2024

What Patients With Breast Cancer Need to Know About ADC-Related Fatigue

Author(s):

Alex Biese

Researchers have found that treatment with antibody-drug conjugates is associated with fatigue among patients with breast cancer.

Image of a doctor holding treatment on an IV pole.

Fatigue is the most common side effect from ADC treatments for breast cancer, an expert told CURE®.

Nearly 40% of patients with breast cancer treated with antibody-drug conjugates (ADCs) experienced fatigue, according to recently published study findings.

The study’s findings, published in Critical Reviews in Oncology/Hematology, analyzed data from 7.963 patients participating in 31 studies. Researchers found that there was a 39.84% incidence of all-grade fatigue during treatment via ADC monotherapy.

Researchers noted that fatigue is the most common side effect among the three ADCs that have been approved by the Food and Drug Administration for breast cancer. These three included Enhertu (trastuzumab deruxtecan; T-DXd), Kadclya (trastuzumab emtansine; T-DM1) and Trodelvy (sacituzumab govitecan).

A subgroup analysis in the study found treatment-specific rates of ADC-induced fatigue to be 47.05% with Enhertu, 42.82% with Trodelvy and 35.17% with Kadclya. Fatigue, researchers said, was also more common with T-DM1 combination therapy than with monotherapy.

But fatigue is multifactorial, as nurse practitioner Jamie Carroll of the Mayo Clinic in Rochester, Minnesota explained.

“Our patients do have fatigue on antibody-drug conjugates,” said Carroll. “But I don't think that you can exactly say that fatigue is related only to our medications. Fatigue, yes, is related to the medications that our patients are receiving. But I also think that fatigue is related to the fact that maybe they're not sleeping well, maybe our patients are having multiple episodes of diarrhea, and they're back and forth to the bathroom [at night]. And so yes, that's related to the drug, but it's not directly related to the drug, it's related to side effects from the medications themselves.”

Carroll noted that fatigue is cyclical, and also compounds in itself, where patients feel worse on subsequent cycles of treatment or find fatigue lasting longer.

“If you ever have questions of, ‘Is this how I'm supposed to be feeling? Or is this worse than I'm supposed to feel?’ I would say reach out to your care team so that they can walk you through and they can tell you how you should be feeling, or [they can find out if] this is more than what we would anticipate because I would never want a patient to get into a situation where they get too dehydrated. And that's compounding things. Or they end up with a fever and that's making fatigue worse. So anytime you are questioning things, reach out to your care team so that they can help understand and walk you through how you should be feeling.”

“Fatigue has a serious negative effect on the patient’s physical and mental health,” researchers wrote in the study. “Furthermore, it can significantly increase the incidence of depression and sleep disturbances and greatly reduce the quality of life of patients.” Researchers also noted that, during chemotherapy, “fatigue can lead to the interruption of treatment, thereby affecting the long-term survival of patients.”

Carroll agreed that unchecked fatigue can lead to worse patient outcomes.

“It's really important that patients are as upfront as possible [with their care teams],” she said. “And so with that, I think it's also important that you journal so that when you're with your provider at that appointment, you can look back over the course of 14, 21 days, however long your cycle is, and you can say, ‘This is how I felt on days 1, 2, 3, 4,’ whatever that cycle is, so you can share those updates so that your provider can accurately dose your treatment, based on how you felt the last couple of weeks.”

To manage fatigue, Carroll advised that patients make two lists: the things they want to do, and the things they have to do.

“This is really hard for patients, but I try to get them to say the things that they have to do, to give those to somebody else,” she said. “And so those are things that are like cleaning the bathrooms or making dinner. So, those are things that are on the list that you have to get done every day, but delegate those to somebody else.

“And then, the things that you want to do, like play with your kids, or walk to the park, those are the things that I want you to do. So, it's really planning your day around the things that bring you joy, not the things that are on your list, because the toilets have to get cleaned, but who wants to do that? Nobody. And so really planning so that you're focused on the things that bring you joy and the things that you want to do, and so really kind of focusing on those things, and so I think because of that, you're really better managing and keeping your energy [focused] on those things that you'd want to do. And so, you're not expending all of your energy on the things that don't bring you joy.”

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of two doctors with text.
Imiage of two doctors with text.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Image of woman.
Picture of Dr. Pouneh Razavi
Image of a woman wearing a headband and glasses
Image of doctor.
Image of woman.
Related Content
Advertisement
Image of women with text.
June 25th 2025

June Breast Cancer Highlights: Top 5 Updates Patients Should Know

Ryan Scott
June brought major breast cancer updates, and CURE is sharing the latest treatment combinations, biomarker-driven care and patient well-being.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Dr. Rita Mukhtar sits down for a conversation with Dr. Joshua Sabari to discuss the potential use of ctDNA to guide breast cancer therapy: © stock.adobe.com.
June 24th 2025

How a Blood Test May Help Guide Breast Cancer Treatment

Ryan Scott
Dr. Rita Mukhtar sits down for a conversation with Dr. Joshua Sabari to discuss the potential use of ctDNA to guide breast cancer therapy.
Cancer Horizons podcast logo
December 12th 2023

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
After my breast cancer diagnosis, faith guided me through fear: © stock.adobe.com.
June 23rd 2025

Faith, Friendship and Finding Purpose After Breast Cancer

Shirley Rakuljic
After my breast cancer diagnosis, faith guided me through fear, and in passing on a blessed bracelet, I found healing and an unexpected reconnection.
Advocacy text.
June 19th 2025

Self-Advocacy Can Help Patients Navigate Cancer Treatment Challenges

Mindy Sue Cohen
Speaking up during cancer treatment helped one patient manage side effects, address insurance issues and stay productive throughout chemotherapy.
Related Content
Advertisement
Image of women with text.
June 25th 2025

June Breast Cancer Highlights: Top 5 Updates Patients Should Know

Ryan Scott
June brought major breast cancer updates, and CURE is sharing the latest treatment combinations, biomarker-driven care and patient well-being.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Dr. Rita Mukhtar sits down for a conversation with Dr. Joshua Sabari to discuss the potential use of ctDNA to guide breast cancer therapy: © stock.adobe.com.
June 24th 2025

How a Blood Test May Help Guide Breast Cancer Treatment

Ryan Scott
Dr. Rita Mukhtar sits down for a conversation with Dr. Joshua Sabari to discuss the potential use of ctDNA to guide breast cancer therapy.
Cancer Horizons podcast logo
December 12th 2023

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
After my breast cancer diagnosis, faith guided me through fear: © stock.adobe.com.
June 23rd 2025

Faith, Friendship and Finding Purpose After Breast Cancer

Shirley Rakuljic
After my breast cancer diagnosis, faith guided me through fear, and in passing on a blessed bracelet, I found healing and an unexpected reconnection.
Advocacy text.
June 19th 2025

Self-Advocacy Can Help Patients Navigate Cancer Treatment Challenges

Mindy Sue Cohen
Speaking up during cancer treatment helped one patient manage side effects, address insurance issues and stay productive throughout chemotherapy.
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.